XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q9)Sep 30, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 29.36%984.33M | ---- | 69.42%760.92M | ---- | 31.55%449.14M | ---- | 100.48%341.43M | ---- | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -291.67%-59.77M | ---- | -618.75%-15.26M | ---- | -27.43%-2.12M | ---- | 58.91%-1.67M | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | 66.81%7.88M | ---- | 14,665.63%4.73M | ---- | --32K | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | -168.81%-10.41M | ---- | 422.85%15.13M | ---- | -52.37%-4.69M | ---- | 61.56%-3.08M | ---- | ---- |
-Other fair value changes | ---- | -168.81%-10.41M | ---- | 422.85%15.13M | ---- | -52.37%-4.69M | ---- | 61.56%-3.08M | ---- | ---- |
Asset sale loss (gain): | ---- | -65.82%377K | ---- | 80.82%1.1M | ---- | -1.61%610K | ---- | -45.85%620K | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -65.82%377K | ---- | 80.82%1.1M | ---- | -1.61%610K | ---- | -45.85%620K | ---- | ---- |
Depreciation and amortization: | ---- | 27.79%145.44M | ---- | 22.36%113.81M | ---- | 21.32%93.01M | ---- | -7.31%76.67M | ---- | ---- |
-Amortization of intangible assets | ---- | 12.99%17.37M | ---- | 12.45%15.37M | ---- | 123.17%13.67M | ---- | 29.44%6.13M | ---- | ---- |
Financial expense | ---- | -16.68%13.29M | ---- | -30.02%15.95M | ---- | 83.00%22.79M | ---- | 79.69%12.46M | ---- | ---- |
Exchange Loss (gain) | ---- | 93.73%-291K | ---- | -111.85%-4.64M | ---- | 94.27%39.17M | ---- | 152.90%20.16M | ---- | ---- |
Special items | ---- | -34.22%91.69M | ---- | 106.34%139.39M | ---- | 83.39%67.55M | ---- | --36.84M | ---- | ---- |
Operating profit before the change of operating capital | ---- | 13.71%1.17B | ---- | 54.94%1.03B | ---- | 37.66%665.5M | ---- | 88.09%483.43M | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 141.99%413.26M | ---- | -131.24%-984.1M | ---- | -229.58%-425.56M | ---- | 180.33%328.42M | ---- | ---- |
Accounts receivable (increase)decrease | ---- | -23.46%-340.51M | ---- | 30.43%-275.81M | ---- | -6,579.13%-396.46M | ---- | -88.00%6.12M | ---- | ---- |
Accounts payable increase (decrease) | ---- | -93.74%36.77M | ---- | 63.58%587.36M | ---- | 337.78%359.06M | ---- | -224.83%-151M | ---- | ---- |
Cash from business operations | -15.81%435.29M | 257.53%1.28B | -3.13%517.01M | 77.04%358.59M | 345.60%533.71M | -69.63%202.54M | -29.47%119.77M | 198.86%666.97M | -12.98%178.82M | 132.25%169.82M |
Other taxs | -95.63%-121.11M | ---- | -50.74%-61.91M | ---- | -208.60%-41.07M | ---- | 31.86%-13.31M | ---- | -390.95%-47.06M | -47.43%-19.53M |
Special items of business | ---- | -216.61%-610.79M | ---- | -46.14%523.79M | ---- | 290.20%972.53M | ---- | ---511.31M | ---- | ---- |
Net cash from operations | -30.97%314.18M | -23.92%671.28M | -7.62%455.11M | -24.91%882.37M | 362.73%492.65M | 654.92%1.18B | -29.16%106.47M | -24.42%155.65M | -40.56%131.77M | 151.01%150.29M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 18.82%25.7M | 291.67%59.77M | 627.66%21.63M | 618.75%15.26M | 696.78%2.97M | 23.22%2.12M | -69.12%373K | -57.55%1.72M | -47.83%1.43M | -35.37%1.21M |
Sale of fixed assets | ---- | 133.36%2.62M | ---- | 37.24%1.12M | -49.10%197K | 48.10%819K | 66.09%387K | -97.22%553K | -91.34%553K | -58.39%233K |
Purchase of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 6.80%-129.75M | 6.58%-83.69M | ---- |
Acquisition of subsidiaries | --121.56M | ---- | ---- | ---1.07M | ---8.19M | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | -20.85%3.09M | 183.86%204.76M | --3.91M | ---244.17M | ---- | ---- | -25.84%1.15M | --8.83M | --8.2M | --1.55M |
Cash on investment | -32.97%-645.89M | 24.72%-675.28M | 22.08%-485.74M | -97.43%-897.07M | -199.14%-623.38M | ---454.37M | -246.71%-208.39M | ---- | ---- | 6.11%-60.11M |
Other items in the investment business | 1,472.50%629K | ---- | --40K | ---- | ---- | 119.26%3.3M | ---- | -74.06%-17.13M | -74.06%-17.13M | ---- |
Net cash from investment operations | -7.55%-494.91M | 63.75%-408.13M | 26.77%-460.17M | -151.25%-1.13B | -204.34%-628.4M | -230.07%-448.13M | -261.52%-206.48M | 35.90%-135.77M | 49.01%-90.63M | 57.88%-57.12M |
Net cash before financing | -3,468.98%-180.73M | 208.04%263.15M | 96.27%-5.06M | -133.50%-243.56M | -35.73%-135.76M | 3,555.88%726.94M | -207.35%-100.02M | 438.57%19.88M | -6.35%41.14M | 223.01%93.17M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -76.10%103M | -67.21%26.64M | -10.66%430.92M | -40.85%81.24M | -27.57%482.33M | -77.47%137.33M | 830.34%665.93M | 1,252.02%656.8M | 1,162.51%609.53M |
Refund | -20.87%-84.49M | 50.48%-180M | -179.60%-69.9M | 34.40%-363.48M | ---25M | 18.80%-554.07M | ---- | -516.87%-682.33M | -441.00%-682.33M | -830.95%-597.93M |
Issuing shares | ---- | 60,126,200.00%601.26M | --567.21M | -100.00%1K | ---- | --571.6M | --493.98M | ---- | ---- | ---- |
Interest paid - financing | 60.17%-4.23M | -7.41%-14.22M | -33.97%-10.62M | 41.90%-13.24M | 31.52%-7.93M | -83.00%-22.79M | -204.07%-11.58M | -79.69%-12.46M | -40.92%-7.84M | -3.28%-3.81M |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---30M | ---30M | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---7.54M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | 58.42%59.24M | -66.62%3.34M | --37.39M | --10M | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from financing operations | -107.76%-42.47M | 788.65%506.98M | 1,116.35%547.65M | -87.18%57.05M | -92.33%45.02M | 1,553.98%444.99M | 8,486.53%587.15M | 56.22%-30.61M | 67.31%-34.74M | 115.70%6.84M |
Effect of rate | -132.32%-6.26M | 253.01%28.2M | -23.78%19.36M | 115.92%7.99M | 332.56%25.4M | -208.77%-50.17M | -294.32%-10.92M | -415.45%-16.25M | -267.33%-5.95M | 120.86%5.62M |
Net Cash | -141.14%-223.21M | 512.92%770.12M | 698.00%542.59M | -115.91%-186.51M | -118.63%-90.73M | 11,031.13%1.17B | 387.09%487.13M | 85.85%-10.72M | 110.26%6.4M | 183.84%100.01M |
Begining period cash | 58.26%2.17B | -11.53%1.37B | -11.53%1.37B | 262.63%1.55B | 262.63%1.55B | -5.38%427.12M | -5.38%427.12M | -13.53%451.4M | -13.53%451.4M | -13.53%451.4M |
Cash at the end | 0.36%1.94B | 58.26%2.17B | 30.25%1.93B | -11.53%1.37B | 64.23%1.48B | 264.93%1.55B | 62.17%903.33M | -5.97%424.43M | -2.46%451.85M | 37.44%557.03M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.